Remdesivir for the treatment of COVID-19

Author:

Grundeis Felicitas1,Ansems Kelly2,Dahms Karolina2,Thieme Volker1,Metzendorf Maria-Inti3,Skoetz Nicole4,Benstoem Carina2,Mikolajewska Agata56,Griesel Mirko1,Fichtner Falk1,Stegemann Miriam6

Affiliation:

1. Department of Anaesthesiology and Intensive Care; University of Leipzig Medical Center; Leipzig Germany

2. Department of Intensive Care Medicine and Intermediate Care; Medical Faculty, RWTH Aachen University; Aachen Germany

3. Institute of General Practice; Medical Faculty of the Heinrich-Heine-University Düsseldorf; Düsseldorf Germany

4. Cochrane Haematology, Department I of Internal Medicine; University of Cologne, Faculty of Medicine and University Hospital Cologne; Cologne Germany

5. Centre for Biological Threats and Special Pathogens (ZBS), Strategy and Incident Response, Clinical Management and Infection Control; Robert Koch Institute; Berlin Germany

6. Department of Infectious Diseases and Respiratory Medicine; Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Berlin Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference240 articles.

1. Remdesivir for the treatment of COVID-19 - final report;Beigel;New England Journal of Medicine,2020

2. Remdesivir for the treatment of COVID-19 - preliminary report;Beigel;New England Journal of Medicine,2020

3. Beigel JH Tomashek KM Dodd LE Remdesivir for the treatment of COVID-19 - preliminary report New England Journal of Medicine 10.1056/NEJMc2022236 32649078

4. Epstein M Avoiding the termination of ACTT European Heart Journal 2020 10.1093/eurheartj/ehaa546

5. A multicenter, adaptive, randomised blinded controlled trial of the safety and efficacy of investigational therapeutics for the treatment of COVID-19 in hospitalised adults - version for European Union/United Kingdom sites www.clinicaltrialsregister.eu/ctr-search/search?query=EUCTR2020-001052-18-DE

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3